We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
-0.82%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.61B
AUM Growth
+$447M
(+39%)
Cap. Flow
+$533M
Cap. Flow
% of AUM
33.15%
Top 10 Holdings %
Top 10 Hldgs %
11.86%
Holding
2,259
New
642
Increased
549
Reduced
466
Closed
595
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$39.8M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$32.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28.3M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$23.1M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$4.13M |
| 2 |
NVIDIA
NVDA
|
+$4.12M |
| 3 |
Pfizer
PFE
|
+$4.01M |
| 4 |
Cheniere Energy
LNG
|
+$3.83M |
| 5 |
HOLX
Hologic
HOLX
|
+$3.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.44% |
| 2 | Technology | 13.16% |
| 3 | Healthcare | 12.56% |
| 4 | Industrials | 12.44% |
| 5 | Consumer Discretionary | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
AC Immune
ACIU
$234M
| $32K | ﹤0.01% |
+11,530
| New | +$35.8K |
|
1627
Milestone Pharmaceuticals
MIST
$141M
| $32K | ﹤0.01% |
26,893
-209,245
| -89% | -$366K |
|
1628
Fathom Holdings
FTHM
$30.1M
| $31K | ﹤0.01% |
57,542
+4,373
| +8% | +$4.38K |
|
1629
Rocky Mountain Chocolate Factory
RMCF
$8.03M
| $31K | ﹤0.01% |
+13,719
| New | +$32.1K |
|
1630
Westwater Resources
WWR
$50.8M
| $31K | ﹤0.01% |
46,822
+25,759
| +122% | +$23.2K |
|
1631
Upland Software
UPLD
$13.1M
| $30K | ﹤0.01% |
4,453
-11,806
| -73% | -$124K |
|
|
ELME
1632
Elme Communities
ELME
$144M
| $28K | ﹤0.01% |
+14,024
| New | +$46.2K |
|
1633
VistaGen Therapeutics
VTGN
$9.45M
| $28K | ﹤0.01% |
+49,842
| New | +$30.3K |
|
1634
American Vanguard Corp
AVD
$75.2M
| $26K | ﹤0.01% |
+10,361
| New | +$44.1K |
|
|
CANG
1635
Cango Inc
CANG
$69.7M
| $26K | ﹤0.01% |
+6,437
| New | +$61.3K |
|
1636
Solana Company
HSDT
$98.1M
| $26K | ﹤0.01% |
+15,047
| New | +$36.6K |
|
1637
MDxHealth
MDXH
$21.5M
| $26K | ﹤0.01% |
11,092
-59,804
| -84% | -$203K |
|
1638
Expensify
EXFY
$175M
| $25K | ﹤0.01% |
29,136
+6,526
| +29% | +$7.74K |
|
1639
Phio Pharmaceuticals
PHIO
$12.2M
| $24K | ﹤0.01% |
+19,864
| New | +$22.7K |
|
1640
New Fortress Energy
NFE
$96.4M
| $22K | ﹤0.01% |
36,688
-381,167
| -91% | -$446K |
|
|
IOBT
1641
DELISTED
IO Biotech
IOBT
| $20K | ﹤0.01% |
+348,352
| New | +$119K |
|
1642
PMV Pharmaceuticals
PMVP
$62.9M
| $19K | ﹤0.01% |
+15,441
| New | +$19.6K |
|
1643
BRC Inc
BRCC
$116M
| $18K | ﹤0.01% |
+23,466
| New | +$19.8K |
|
1644
Brilliant Earth
BRLT
$18M
| $18K | ﹤0.01% |
13,666
-51,660
| -79% | -$77.8K |
|
|
MI
1645
NFT Ltd
MI
$2.06M
| $18K | ﹤0.01% |
+670
| New | +$184K |
|
1646
Greenland Technologies Holding
GTEC
$14.1M
| $17K | ﹤0.01% |
+24,789
| New | +$21.5K |
|
1647
Jasper Therapeutics
JSPR
$23.1M
| $17K | ﹤0.01% |
19,084
-55,880
| -75% | -$77.6K |
|
|
MTEN
1648
Mingteng International Corp
MTEN
$7.31M
| $17K | ﹤0.01% |
+13,746
| New | +$227K |
|
1649
KALA BIO
KALA
$12.5M
| $15K | ﹤0.01% |
+1,689
| New | +$35.7K |
|
1650
CalciMedica
CALC
$11.1M
| $13K | ﹤0.01% |
+23,777
| New | +$48.3K |
|
Similar funds
ACB
FWP
RC
SCI
SCM
BW
TLFA
HH
GSA Capital Partners's Q1 2026 Portfolio in Review
As of Q1 2026, GSA Capital Partners held 2,259 positions worth $1.61B, up 39% from $1.16B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
GSA Capital Partners deployed $533M of net new capital in Q1 2026, opening 642 new positions and adding to 549 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $4.12M trimmed.
- GSA Capital Partners's largest Q1 2026 buy was Vanguard Intermediate-Term Corporate Bond ETF: 389,989 shares worth $32.3M.
- GSA Capital Partners added most to Vanguard Short-Term Corporate Bond ETF in Q1 2026, an estimated $39.8M increase.
- GSA Capital Partners's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $4.12M.
- GSA Capital Partners fully exited EOG Resources in Q1 2026, selling an estimated $4.13M.
- GSA Capital Partners's ten largest holdings make up 12% of its $1.61B portfolio in Q1 2026.
- GSA Capital Partners opened 642 new positions and closed 595 in Q1 2026.
- GSA Capital Partners's portfolio value rose 39% quarter-over-quarter to $1.61B.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.